Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 1000

Metabolome profiling of S cerevisiae with drugs targeting receptors and enzymes

ABSTRACT: Saccharomyces cerevisiae were treated with drugs known to target receptors or enzymes within the yeast. Metabololite extracts were extracted and subjected to flow injection analysis.

INSTRUMENT(S): 6550 iFunnel Q-TOF LC/MS

ORGANISM(S): Saccharomyces Cerevisiae (ncbitaxon:4932)

SUBMITTER: Uwe Sauer

PROVIDER: MSV000088124 | MassIVE | Mon Sep 20 07:34:00 BST 2021

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Similar Datasets

GNPS Metabolome profiling of S cerevisiae with drugs targeting receptors and enzymes

Project description:Saccharomyces cerevisiae were treated with drugs known to target receptors or enzymes within the yeast. Metabololite extracts were extracted and subjected to flow injection analysis.

| MSV000088124 | GNPS

Strain abundance assay of barcoded heterozygous and homozygous yeast single gene deletion strains exposed to 87 psychoactive drugs

Project description:To profile off-target effects of psychoactive drugs, 87 genome-wide drug fitness assays (of which 5 were performed in duplicate) and 18 genome-wide control experiments were performed in Saccharomyces cerevisiae. Heterozygous and homozygous yeast single gene deletion strains from the BY collection of the Saccharomyces cerevisiae genome deletion consortium were used.

2008-07-07 | E-MTAB-34 | biostudies-arrayexpress

Expression analysis of novel and known antifungal drugs using S. cerevisiae as a model

Project description:A systematic approach allowing the identification of the molecular way of action of novel potential drugs still represents the golden-tool for drug-discovery researchers. While high-throughput screening technologies of large libraries is now well established, the assessment of the drug targets and mechanism of action is still under development. Taking advantage of the yeast model Saccharomyces cerevisiae, we herein applied BarSeq, a Next Generation Sequencing based method to the analysis of both haploinsufficiency and homozygous fitness effects of a novel antifungal drug compared to the well-known antifungal, ketoconazole. Integrative bioinformatic analysis of BarSeq, whole genome expression analysis and classical biological assays identified the target and cell pathways affected by the novel antifungal. Confirmation of the effects observed in the yeast model as well as in pathogenic fungi further demonstrated the reliability of the multi-sided approach and the novelty of the targets and mode of action of the new class of molecules studied that thus represent a valuable source of novel antifungals.

2016-12-30 | GSE42418 | GEO

Effect of putative GPR1 antagonists on the metabolome profile of Saccharomyces cerevisiae

Project description:Saccharomyces cerevisiae was treated with 10 uM of the indicated drugs for a duration of 30 minutes before the intracellular metabolome was collected. Samples were subjected to LCMS analysis in negative mode with separation by an InfinityLab Poroshell 120 HILIC-Z column (2.1 x 100 mm, 2.7 um, Agilent)

2021-05-13 | MSV000087420 | MassIVE

Identification of NAD+ capped mRNAs in S. cerevisiae

Project description:We report the identification of NAD-RNA in the yeast Saccharomyces cerevisiae under two distinct growth mediums.

2016-11-30 | GSE90636 | GEO

Transcriptome profile of tra1 mutant in S. cerevisiae

Project description:Tra1 is an essential component of the SAGA and NuA4 transcriptional co-activator complexes and is linked to multiple cellular processes associated with the yeast response to antifungal drugs. This submission contains RNA sequencing data from Saccharomyces cerevisiae strains expressing a Tra1 mutant with three arginine to glutamine mutations in the PI3K domain (tra1Q3; Berg et al., 2018). Our goal was to identify how gene expression changes due to mutation to the PI3K domain of Tra1.

2021-03-15 | GSE168955 | GEO

Barcode sequencing of Saccharomyces cerevisiae deletion libraries, SYBARIS project

Project description:A systematic approach allowing the identification of the molecular way-of-action of novel potential drugs represents the golden-tool for drug-discovery. While high-throughput screening technologies of large libraries is now well established, the assessment of the drug targets and mechanism of action is still under development. Taking advantage of the yeast model Saccharomyces cerevisiae, we herein applied BarSeq, a Next Generation Sequencing-based method to the analysis of both haploinsufficiency and homozygous fitness effects of a novel antifungal drug ('089') compared to the well-known antifungal ketoconazole. '089' was a novel compound identified in during a screen for antifungal drugs, as it was showing fungicidal effects, and able to affect the yeast fitness at the mitochondrial level (Stefanini et al., 2010. (Dissection of the Effects of Small Bicyclic Peptidomimetics on a Panel of Saccharomyces cerevisiae Mutants;.J Biol Chem, 285: 23477-23485.) Integrative bioinformatic analysis of BarSeq, whole genome expression analysis and classical biological assays identified the target and cell pathways affected by the novel antifungal. Confirmation of the effects observed in the yeast model and in pathogenic fungi further demonstrated the reliability of the multi-sided approach and the novelty of the targets and way-of-action of the new class of molecules studied representing a valuable source of novel antifungals.

2016-04-30 | E-SYBR-6 | biostudies-arrayexpress

Transcriptional responses of Saccharomyces cerevisiae and Lachancea thermotolerans in mixed-culture wine fermentation

Project description:In wine fermentation, the blending of non-Saccharomyces yeast with Saccharomyces cerevisiae to improve the complexity of wine has become common practice, but data regarding the impact on yeast physiology and on genetic and metabolic regulation remain limited. Here we describe a transcriptomic analysis of single species and mixed species fermentations.

2019-02-01 | GSE112581 | GEO

Saccharomyces cerevisiae & stress

Project description:Next-generation proteomics of Saccharomyces cerevisiae for defining the response of this yeast to lanthanides.

2022-04-23 | PXD010700 | Pride

RNA-seq data from three Saccharomyces cerevisiae strains with different protein productivity

Project description:The budding yeast Saccharomyces cerevisiae is a popular host to be used to produce recombinant proteins. Here we studied three yeast strains with different productivity using the RNA-seq data to elucidate the mechanisms for improving protein production.

2020-10-26 | GSE147204 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data